Neurotech Pharmaceuticals, Inc., today announced that it was reported in the Proceedings of the National Academy of Sciences (PNAS) (online March 28, 2011) that its product candidate NT-501 slowed progression of vision loss in patients with geographic …
Category: News
Better Treatment Sought For Blinding Traumatic Optic Nerve Damage
Scientists want to protect the optic nerve when the eye takes a blow on the battlefield or in a car wreck. It’s called traumatic optic nerve damage when the fragile, spaghetti-sized nerve tethered to the back of the eye gets rattled, resulting in swe…
A 62-Year-Old Woman With a Growing Mass
A 62-year-old woman presents with a mass near her eye that has been slowly growing for a year. What is your diagnosis? Medscape Ophthalmology
Neurotech’s NT-501 intraocular implant slows progression of vision loss in GA subjects
Neurotech Pharmaceuticals, Inc., today announced that it was reported in the Proceedings of the National Academy of Sciences that its product candidate NT-501 slowed progression of vision loss in patients with geographic atrophy (GA) associated with dr…
Sleeping Difficulties Increase Risk Of Eye Disease In People With Diabetes
People with Type 2 diabetes who have obstructive sleep apnoea[1] (OSA) are more at risk of losing their sight due to severe retinopathy[2], as well as foot problems and possible amputation because of neuropathy[3], according to new research…
Merck enters definitive agreement to acquire Inspire
Merck, known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which Merck will acquire Inspire, a specialty pharmaceutical company focused on develop…
Neurotech’s NT-501 Implant Slows Vision Loss In Patients With Geographic Atrophy Associated With Dry AMD As Reported In PNAS
Neurotech Pharmaceuticals, Inc., today announced that it was reported in the Proceedings of the National Academy of Sciences (PNAS) (online March 28, 2011) that its product candidate NT-501 slowed progression of vision loss in patients with geographic …
Visco Technologies To Represent New Anika Product – ANIKAVISCT Is A Newly Approved Ophthalmic Viscoelastic
PRAIRE VILLAGE, KS– Kansas City-based Visco Technologies LLC announced today that it will serve as a U.S. Distributor for Anika Therapeutics Inc.’s (Nasdaq:ANIK) ANIKAVISCT viscoelastic for cataract surgery. Anika recently received US Food and Drug Ad…
Quality Reinverted Images During Vitreoretinal Surgery With ROLS®
Enabling a completely custom surgical microscope fit, Volk Optical’s new ROLS (Infinity) reinverter is the most technically advanced viewing system for reinverted images during vitreoretinal surgery. Used to correctly orient the images created by non c…
Better Treatment Sought For Blinding Traumatic Optic Nerve Damage
Scientists want to protect the optic nerve when the eye takes a blow on the battlefield or in a car wreck.
Glaukos Corporation Named To The Wall Street Journal’s "The Next Big Thing" List
Glaukos has been named to The Wall Street Journal’s “The Next Big Thing” list, which seeks to identify and rank venture-backed companies across all industries that have the capital, executive experience and investor know-how to succeed. Glaukos was sel…
Minimally Invasive Glaucoma Surgery (MIGS)
Technology Spotlight
Sleeping Difficulties Increase Risk Of Eye Disease In People With Diabetes
People with Type 2 diabetes who have obstructive sleep apnoea[1] (OSA) are more at risk of losing their sight due to severe retinopathy[2], as well as foot problems and possible amputation because of neuropathy[3], according to new research.
Senate Nixes 1099 Requirement, Obama’s Signature Is Next
The business community and organized medicine had lobbied hard for the repeal of Although President Barack Obama agrees with both parties that an onerous tax- reporting duty in the Affordable Care Act Act.ought to go, he disagrees on how to offset the …
Proposed GOP 2012 Budget Turns Medicare Into Subsidy Program
The proposal also calls for a 10-year “doc fix” for the Medicare reimbursement crisis and a cap on noneconomic damages in medical malpractice cases. Medscape Medical News
Why You Must Prepare for the ICD-10 Now
Although ICD-10 coding isn’t required until 2013, there are some key issues that it pays to start getting ready now. Medscape Business of Medicine
Lupin Sued by Allergan in US Over Eye Drug
The US subsidiary of the Indian drugmaker Lupin has been sued by the US firm Allergan alleging that the former would be infringing its patent coverage by attempting to manufacture and market a generic version of Zymaxid 0.5% (Gatifloxacin opthalmic sol…
Neurotech’s NT-501 Implant Slows Vision Loss in Patients with Geographic Atrophy Associated with Dry AMD as Reported in PNAS
LINCOLN, R.I.–(BUSINESS WIRE)–Neurotech announced that it was reported in PNAS that its product candidate NT-501 slowed progression of vision loss in patients with geographic atrophy associated with dry AMD in a Phase 2 study.
Set Your Sights On Spring Eye Allergy Relief
With the record-breaking cold and snow the country experienced this winter, spring will be a much welcomed relief. But, for many Americans who suffer from allergies, warmer weather brings the onset of sneezing, coughing and itchy, watery eyes…
Study Offers First Look At Asian Americans’ Glaucoma Risk
It’s generally known that African Americans have the highest risk for glaucoma (about 12 percent) among racial groups in the United States. They are more than twice as likely as non-Hispanic white Americans (5.6 percent) to develop this potentially bli…